{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:03:23Z","timestamp":1779393803300,"version":"3.53.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"The Federal Ministry of Education and Research, Germany","award":["202060457"],"award-info":[{"award-number":["202060457"]}]},{"name":"The government of Switzerland"},{"name":"UK aid from the UK government"},{"name":"The European Union's Horizon 2020 research and innovation program","award":["642609"],"award-info":[{"award-number":["642609"]}]},{"name":"The government of The Netherlands"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40258-018-0449-8","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T02:44:45Z","timestamp":1542768285000},"page":"213-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan"],"prefix":"10.1007","volume":"17","author":[{"given":"C\u00e9line","family":"Aerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Jalal","family":"Pashtoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Nahzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Sicuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"449_CR1","unstructured":"World Health Organization. Leishmaniasis: the disease. Geneva: World Health Organization;."},{"issue":"10","key":"449_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0000259","volume":"2","author":"M Kassi","year":"2008","unstructured":"Kassi M, Kassi M, Afghan AK, Rehman R, Kasi PM. Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan. PLoS Negl Trop Dis. 2008;2(10):1\u20133. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0000259\n                    \n                  .","journal-title":"PLoS Negl Trop Dis."},{"issue":"1","key":"449_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-018-5260-9","volume":"18","author":"I Bennis","year":"2018","unstructured":"Bennis I, De Brouwere V, Belrhiti Z, Sahibi H, Boelaert M. Psychosocial burden of localised cutaneous leishmaniasis: a scoping review. BMC Public Health. 2018;18(1):1\u201312. \n                    https:\/\/doi.org\/10.1186\/s12889-018-5260-9\n                    \n                  .","journal-title":"BMC Public Health."},{"key":"449_CR4","volume-title":"Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region. Geneva: World Health Organization; 2014."},{"key":"449_CR5","volume-title":"Weekly epidemiological record","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Weekly epidemiological record. Geneva: World Health Organization; 2016."},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.socscimed.2016.04.038","volume":"167","author":"I Berry","year":"2016","unstructured":"Berry I, Berrang-ford L. Leishmaniasis, conflict, and political terror: a spatio-temporal analysis. Soc Sci Med. 2016;167:140\u20139. \n                    https:\/\/doi.org\/10.1016\/j.socscimed.2016.04.038\n                    \n                  .","journal-title":"Soc Sci Med"},{"issue":"2","key":"449_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","volume":"16","author":"HJC Vries de","year":"2015","unstructured":"de Vries HJC, Reedijk SH, Schallig HDFH. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015;16(2):99\u2013109. \n                    https:\/\/doi.org\/10.1007\/s40257-015-0114-z\n                    \n                  .","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"449_CR8","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1128\/JCM.01286-07","volume":"45","author":"AK Boggild","year":"2007","unstructured":"Boggild AK, Miranda-Verastegui C, Espinosa D, et al. Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru. J Clin Microbiol. 2007;45(11):3680\u20134. \n                    https:\/\/doi.org\/10.1128\/JCM.01286-07\n                    \n                  .","journal-title":"J Clin Microbiol"},{"issue":"4","key":"449_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.trstmh.2006.06.009","volume":"101","author":"A Lineth","year":"2007","unstructured":"Lineth A, Parrado R, De Doncker S, Dujardin J. American tegumentary leishmaniasis: direct species identification of Leishmania in non-invasive clinical samples. Trans R Soc Trop Med Hyg. 2007;101(4):368\u201371. \n                    https:\/\/doi.org\/10.1016\/j.trstmh.2006.06.009\n                    \n                  .","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"449_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Dujardin J-C, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581\u201396. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(07)70209-8\n                    \n                  .","journal-title":"Lancet Infect Dis."},{"issue":"2","key":"449_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3315\/jdcr.2013.1135","volume":"7","author":"A Masmoudi","year":"2013","unstructured":"Masmoudi A, Hariz W, Marrekchi S, Amouri M, Turki H. Old World cutaneous leishmaniasis: diagnosis and treatment. J Dermatol Case Rep. 2013;7(2):31\u201341. \n                    https:\/\/doi.org\/10.3315\/jdcr.2013.1135\n                    \n                  .","journal-title":"J Dermatol Case Rep."},{"issue":"2","key":"449_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","volume":"118","author":"LF Oliveira","year":"2011","unstructured":"Oliveira LF, Schubach AO, Martins MM, et al. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop. 2011;118(2):87\u201396. \n                    https:\/\/doi.org\/10.1016\/j.actatropica.2011.02.007\n                    \n                  .","journal-title":"Acta Trop"},{"issue":"1","key":"449_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12275-015-4656-9","volume":"53","author":"T Notomi","year":"2015","unstructured":"Notomi T, Mori Y, Tomita N, Kanda H. Loop-mediated isothermal amplification (LAMP): principle, features, and future prospects. J Microbiol. 2015;53(1):1\u20135. \n                    https:\/\/doi.org\/10.1007\/s12275-015-4656-9\n                    \n                  .","journal-title":"J Microbiol."},{"key":"449_CR14","unstructured":"CL Detect\u2122 Rapid Test for Cutaneous Leishmaniasis. InBios International Inc.; 2014."},{"issue":"4","key":"449_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4269\/ajtmh.16-0879","volume":"97","author":"WF Refai","year":"2017","unstructured":"Refai WF, Madarasingha NP, Sumanasena B, et al. Efficacy, safety and cost-effectiveness of thermotherapy in the treatment of Leishmania donovani-induced cutaneous leishmaniasis: a randomized controlled clinical trial. Am J Trop Med Hyg. 2017;97(4):1120\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"449_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","volume":"84","author":"A Chrusciak-talhari","year":"2011","unstructured":"Chrusciak-talhari A, Dietze R, Talhari CC, et al. Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Manaus. Brazil. Am J Trop Med Hyg. 2011;84(2):255\u201360. \n                    https:\/\/doi.org\/10.4269\/ajtmh.2011.10-0155\n                    \n                  .","journal-title":"Brazil. Am J Trop Med Hyg."},{"issue":"2","key":"449_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jebm.12245","volume":"10","author":"JA Cardona-Arias","year":"2017","unstructured":"Cardona-Arias JA, L\u00f3pez-Carvajal L, Plata MPT, V\u00e9lez ID. Cost-effectiveness analysis of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis. J Evid Based Med. 2017;10(2):81\u201390.","journal-title":"J Evid Based Med."},{"key":"449_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-7-3","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Coleman PG. Treating cutaneou leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting. BMC Infect Dis. 2007;7:1\u20139. \n                    https:\/\/doi.org\/10.1186\/1471-2334-7-3\n                    \n                  .","journal-title":"BMC Infect Dis"},{"issue":"1","key":"449_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40249-018-0389-4","volume":"7","author":"H-C Stahl","year":"2018","unstructured":"Stahl H-C, Ahmadi F, Nahzat SM, Dong H-J, Stahl K-W, Sauerborn R. Health economic evaluation of moist wound care in chronic cutaneous leishmaniasis ulcers in Afghanistan. Infect Dis Poverty. 2018;7(1):12. \n                    https:\/\/doi.org\/10.1186\/s40249-018-0389-4\n                    \n                  .","journal-title":"Infect Dis Poverty."},{"issue":"1","key":"449_CR20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1086\/648730","volume":"50","author":"AK Boggild","year":"2010","unstructured":"Boggild AK, Valencia BM, Espinosa D, et al. Detection and species identification of leishmania DNA from filter paper lesion impressions for patients with American cutaneous leishmaniasis. Clin Infect Dis. 2010;50(1):e1\u20136. \n                    https:\/\/doi.org\/10.1086\/648730\n                    \n                  .","journal-title":"Clin Infect Dis"},{"issue":"4","key":"449_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1128\/JCM.44.4.1435","volume":"44","author":"E Bensoussan","year":"2006","unstructured":"Bensoussan E, Nasereddin A, Jonas F, Schnur LF, Jaffe CL. Comparison of PCR assays for diagnosis of cutaneous leishmaniasis. J Clin Microbiol. 2006;44(4):1435\u20139. \n                    https:\/\/doi.org\/10.1128\/JCM.44.4.1435\n                    \n                  .","journal-title":"J Clin Microbiol"},{"issue":"4","key":"449_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4269\/ajtmh.2007.77.636","volume":"77","author":"A Barrio","year":"2007","unstructured":"Barrio A, Mora MC, Ramos F, Moreno S, Samson R, Basombr\u00edo MA. Short report: use of kDNA-based polymerase chain reaction as a sensitive and differentially diagnostic method of American tegumentary Leishmaniasis in disease-endemic areas of northern Argentina. Am J Trop Med Hyg. 2007;77(4):636\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"2007","key":"449_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-9292-6-3","volume":"24","author":"P June","year":"2006","unstructured":"June P, Modabber F, Buffet PA, Torreele E, Milon G, Croft SL. Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur; 13\u201315, Paris. Kinetoplastid biology and disease. 2006;24(2007):1\u201324. \n                    https:\/\/doi.org\/10.1186\/1475-9292-6-3\n                    \n                  .","journal-title":"Kinetoplastid biology and disease."},{"key":"449_CR24","unstructured":"World Health Organization. Annex 6. Costs of medicines in current use for the treatment of leishmaniasis. Table A6.1: drug prices (January 2010). Geneva: World Health Organization; 2010."},{"key":"449_CR25","volume-title":"WHO guide to cost-effectiveness analysis","author":"World Health Organization","year":"2003","unstructured":"World Health Organization. WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003."},{"issue":"3","key":"449_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136. \n                    https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x\n                    \n                  .","journal-title":"Clin Exp Dermatol"},{"key":"449_CR27","unstructured":"Global Burden of Disease Study 2015. Disability weights. Seattle (WA):; 2016."},{"key":"449_CR28","volume-title":"WHO methods and data sources for global burden of disease estimates 2000-2015","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. WHO methods and data sources for global burden of disease estimates 2000-2015. Geneva: World Health Organization; 2017."},{"key":"449_CR29","doi-asserted-by":"publisher","unstructured":"Vink MMT, Nahzat SM, Rahimi H, et al. Evaluation of point-of-care tests for cutaneous leishmaniasis diagnosis in Afghanistan. EBioMedicine. 2018 Nov 2. pii: S2352-3964(18)30483-3. \n                    https:\/\/doi.org\/10.1016\/j.ebiom.2018.10.063\n                    \n                  . [Epub ahead of print].","DOI":"10.1016\/j.ebiom.2018.10.063"},{"key":"449_CR30","doi-asserted-by":"crossref","unstructured":"Bertram MY, Lauer JA, Joncheere K De, et al. WHO: Cost-effectiveness thresholds: pros and cons. 2016.","DOI":"10.2471\/BLT.15.164418"},{"issue":"6","key":"449_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/01.meg.0000108347.41221.50","volume":"16","author":"AH Briggs","year":"2004","unstructured":"Briggs AH. Statistical approaches to handling uncertainty in health economic evaluation. Eur J Gastroenterol Hepatol. 2004;16(6):551\u201361. \n                    https:\/\/doi.org\/10.1097\/01.meg.0000108347.41221.50\n                    \n                  .","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"449_CR32","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1016\/S2214-109X(16)30101-2","volume":"4","author":"S Nayagam","year":"2016","unstructured":"Nayagam S, Conteh L, Sicuri E, et al. Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis. Lancet Glob Health. 2016;4(8):e568\u201378. \n                    https:\/\/doi.org\/10.1016\/S2214-109X(16)30101-2\n                    \n                  .","journal-title":"Lancet Glob Health."},{"issue":"5","key":"449_CR33","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1524-4733.2008.00358.x","volume":"11","author":"GR Barton","year":"2008","unstructured":"Barton GR, Briggs AH, Fenwick EAL. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value Health. 2008;11(5):886\u201397. \n                    https:\/\/doi.org\/10.1111\/j.1524-4733.2008.00358.x\n                    \n                  .","journal-title":"Value Health."},{"key":"449_CR34","doi-asserted-by":"crossref","unstructured":"Faulde MK, Heyl G, Mohammed A. Zoonotic cutaneous. The Public Health Image Library. Emerg Infect Dis. 2006;12(10)","DOI":"10.3201\/eid1210.060076"},{"key":"449_CR35","volume-title":"Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the control of leishmaniases","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the control of leishmaniases. Geneva: World Health Organization; 2010."},{"issue":"1","key":"449_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/0022-3859.928","volume":"49","author":"NC Hepburn","year":"2003","unstructured":"Hepburn NC. Cutaneous leishmanaisis: an overview. J Postgrad Med. 2003;49(1):50\u20134.","journal-title":"J Postgrad Med"},{"key":"449_CR37","unstructured":"Afghan Public Health Insitute, Central Statistics Organization, Indian Institute of Health Management Research, World Health Organization. Afghanistan Mortality Survey 2010. 2011."},{"issue":"6","key":"449_CR38","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3201\/eid0906.030026","volume":"9","author":"R Reithinger","year":"2003","unstructured":"Reithinger R, Mohsen M, Aadil K, Sidiqi M, Erasmus P, Coleman PG. Anthroponotic cutaneous leishmaniasis, Kabul. Afghanistan. Emerg Infect Dis. 2003;9(6):727\u20139. \n                    https:\/\/doi.org\/10.3201\/eid0906.030026\n                    \n                  .","journal-title":"Afghanistan. Emerg Infect Dis."},{"key":"449_CR39","unstructured":"Foundation For Innovative New Diagnostics (FIND). Loopamp\u2122 (LAMP) for TB and malaria."},{"key":"449_CR40","unstructured":"Global Burden of Disease Study 2015. Disability weights. Seattle (WA); 2016."}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-018-0449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40258-018-0449-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-018-0449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:27:55Z","timestamp":1574278075000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40258-018-0449-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1007\/s40258-018-0449-8","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"21 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was supported by funds from the European Union\u2019s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant Agreement No. 642609, the Federal Ministry of Education and Research, Germany (KfW Grant Reference no. 202060457, Development of Products for the Prevention, Diagnosis and Treatment of Neglected and Poverty Related Diseases; https:\/\/www.bmbf.de\/en), the UK Aid from the UK Government, the Government of Switzerland and the Government of The Netherlands, which also contributed to the Foundation For Innovative New Diagnostics participation in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"C\u00e9line Aerts, Martijn Vink, Sayed Jalal Pashtoon, Sami Nahzat, Albert Picado, Israel Cruz and Elisa Sicuri have no conflicts of interest that are directly relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was carried out in accordance with the Helsinki Declaration, and approved by the Institutional Review Board of the National Public Health Institute, Ministry of Public Health, Islamic Republic of Afghanistan (Approval No. 361549).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The participants provided written informed consent in a one-on-one session with a member of the study. For illiterate individuals, the informed consent process was conducted in the presence of an impartial witness and for minors, the consent from a parent or guardian had to be obtained to be enrolled in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The datasets generated during and\/or analysed during the current study are available in the figshare repository at https:\/\/doi.org\/10.6084\/m9.figshare.6949043.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"IC, SP and SN provided the study concept and design, acquisition of data, analysis and interpretation, and study supervision. CA and ES contributed to the model design, data analysis and interpretation. CA, ES, IC, AP and MV contributed to the revision of the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}